Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 43 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometryMurdter, T.; Coller, J.; Claviez, A.; Schonberger, F.; Hofmann, U.; Dreger, P.; Schwab, M.
2004Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centreJittiwutikarn, J.; Ali, R.; White, J.; Bochner, F.; Somogyi, A.; Foster, D.
2004Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityColler, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2001Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjectsMoller, S.; Larsen, F.; Khant, A.; Rolan, P.
2002Pharmacokinetic interaction between tacrolimus and diltiazem - dose-response relationship in kidney and liver transplant recipientsJones, T.; Morris, R.
2004Comparison of DNA damage and repair following radiation challenge in buccal cells and lymphocytes using single-cell gel electrophoresisDhillon, V.; Thomas, P.; Fenech, M.
2002An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrationsNoakes, M.; Clifton, P.; Ntanios, F.; Schrapnel, W.; Record, I.; McInerney, J.
2004Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7Toutsikos, P.; Miners, J.; Stapleton, A.; Thomas, A.; Sallustio, B.; Knights, K.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2007The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy malesSargentini-Maier, M.; Rolan, P.; Connell, J.; Tytgat, D.; Jacobs, T.; Pigeolet, E.; Riethuisen, J.; Stockis, A.